Investment
Features
FeesSafety
Academy
More
Pluang+

Compare OUTFRONT Media Inc. Common Stock (OUT) vs 10X Genomics Inc (TXG) Price & Performance

OUTFRONT Media Inc. Common StockTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

OUTFRONT Media Inc. Common Stock vs 10X Genomics Inc — how do they compare? OUTFRONT Media Inc. Common Stock trades at $29.55 (market cap $5.33B), while 10X Genomics Inc trades at $71.84 (market cap $9.35B). The key difference: 10X Genomics Inc is the larger of the two by market cap, and OUTFRONT Media Inc. Common Stock pays a 4.06% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold OUTFRONT Media Inc. Common Stock for 0 Days and 10X Genomics Inc for 91 Days on average.

OUTTXG
Market Cap
$5.33B$9.35B
Volume
1,197,6184,039,449
Sector
Real EstateHealth
52-Week High
$33.90$97.74
52-Week Low
$17.08$11.83
Typical Hold Time
0 Days91 Days
Enterprise Value
$9.43B$8.88B
Dividend Yield
4.06%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

OUTFRONT Media Inc. Common Stock

No Aura AI signal available yet.

10X Genomics Inc

TXG trades at $73.10, down 2.78% on the day, with a bearish technical signal and neutral oscillators. The company reported revenue of $642.82M in 2025 but a net loss of $43.54M, though recent quarters show earnings beats. Analyst consensus is mixed with a $83.30 price target. Positive news includes Atera shipments and a patent victory, but profitability remains a challenge.

The outlook hinges on Atera's commercial success driving future revenue growth and margin improvement. Risks include persistent losses, competitive pressures, and execution delays. Upside potential exists if new platforms gain traction, but investors should weigh high valuation multiples against ongoing unprofitability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OUT
100% Buy0% Sell
Avg holding period · 0 Days
TXG
17% Buy83% Sell
Avg holding period · 91 Days

Top news

Latest headlines on both assets

About OUTFRONT Media Inc. Common Stock

OUTFRONT Media Inc. is a US out-of-home media REIT that provides advertising space on billboard and transit displays across major markets in US and Canada.

Read more on OUT →

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG →